novo nordisk semaglutide products and competitors sued Eli Lilly, alleging misleading ads unfairly compare doses of Zepbound Mounjaro with Wegovy and Ozempic. Tap link in bio for full story Novo Nordisk boosts production as

Tirzepatide for the treatment of obstructive sleep apnea: rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 trial

It also lowers the risk of major cardiovascular events such as stroke, heart attack, or death in adults with type 2 diabetes who also have heart disease, and lowers the risk of worsening kidney disease, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabetes who also have chronic kidney disease

And to those people, I want to say its not your fault. The special also brought together for the first time two major competitors that are expanding the pharmaceutical weight loss drugs conversation: Negelle Morris, senior vice president, cardiometabolic sales of Novo Nordisk Inc., the Danish company behind Ozempic and Wegovy, and Rhonda Pacheco, group vice president of diabetes and obesity for Eli Lilly, the American pharma company that manufactures and sells Mounjaro and Zepbound

If you use the thigh, try the upper arm